Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy.

Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H.

J Clin Pharm Ther. 2004 Feb;29(1):23-30.

PMID:
14748894
2.

The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels.

Ali F, Laurin MY, Larivière C, Tremblay D, Cloutier D.

Can J Clin Pharmacol. 2003 Fall;10(3):101-6.

PMID:
14506507
3.

Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong.

Lee VW, Fan CS, Li AW, Chau AC.

J Clin Pharm Ther. 2009 Aug;34(4):407-14. doi: 10.1111/j.1365-2710.2009.01024.x.

PMID:
19583673
4.
5.

Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease.

Hilleman DE, Monaghan MS, Ashby CL, Mashni JE, Woolley K, Amato CM.

Pharmacotherapy. 2001 Nov;21(11):1415-21.

PMID:
11714215
6.

Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention.

Carrington MJ, Retegan C, Johnston CI, Jennings GL, Stewart S.

J Clin Nurs. 2009 Mar;18(5):678-86. doi: 10.1111/j.1365-2702.2008.02507.x. Epub 2008 Nov 25.

PMID:
19077020
7.

Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study.

Lindholm LH, Ekbom T, Dash C, Isacsson A, Scherstén B.

J Intern Med. 1996 Jul;240(1):13-22.

PMID:
8708586
8.
10.

Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure.

López Cabezas C, Falces Salvador C, Cubí Quadrada D, Arnau Bartés A, Ylla Boré M, Muro Perea N, Homs Peipoch E.

Farm Hosp. 2006 Nov-Dec;30(6):328-42. English, Spanish.

11.

A randomized controlled trial of a public health nurse directed treatment program for rural patients with high blood cholesterol.

Ammerman AS, Keyserling TC, Atwood JR, Hosking JD, Zayed H, Krasny C.

Prev Med. 2003 Mar;36(3):340-51.

PMID:
12634025
12.

Lipid management and cholesterol goal attainment in Norway.

Ose L, Skjeldestad FE, Bakken IJ, Levorsen A, Alemao EA, Yin DD, Borgström F, Jönsson L.

Am J Cardiovasc Drugs. 2006;6(2):121-8.

PMID:
16555865
13.

Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia.

Paulós CP, Nygren CE, Celedón C, Cárcamo CA.

Ann Pharmacother. 2005 May;39(5):939-43. Epub 2005 Apr 12.

PMID:
15827075
14.
16.

Home-based medication review in a high risk elderly population in primary care--the POLYMED randomised controlled trial.

Lenaghan E, Holland R, Brooks A.

Age Ageing. 2007 May;36(3):292-7. Epub 2007 Mar 26.

PMID:
17387123
17.

Development and evaluation of a patient-oriented education system for diabetes management.

Lee TI, Yeh YT, Liu CT, Chen PL.

Int J Med Inform. 2007 Sep;76(9):655-63. Epub 2006 Jul 3.

PMID:
16815741
18.

Supplemental Content

Support Center